Estrogen/progestogen Receptor
The estrogen/progestogen receptors are activated by the hormone estrogen/progesterone and regulate the gene transcription.
Products Related to Estrogen/progestogen Receptor(156)
- GC48979Estradiol 17-(β-D-Glucuronide) (sodium salt hydrate)Purity: >95.00%
A substrate of multidrug resistance protein 2
- GC4916116α-hydroxy DehydroepiandrosteroneCAS: 1232-73-1Purity: >95.00%
A metabolite of dehydroepiandrosterone
- GC49189(E/Z)-4-hydroxy Tamoxifen-d5CAS: 2470232-57-4Purity: >99.00%
An internal standard for the quantification of (E/Z)-4-hydroxy tamoxifen
- GC493265β-DihydroprogesteroneCAS: 128-23-4Purity: >95.00%
A progesterone receptor agonist and metabolite of progesterone
- GC49520(S)-EquolCAS: 531-95-3Purity: >99.00%
(S)-Equol is an isoflavone compound produced by the gut microbiota of some individuals, primarily derived from the metabolism of daidzein in soybeans by specific gut bacteria. (S)-Equol exhibits significant estrogenic activity and antioxidant properties, binding to estrogen receptors with an affinity for ERβ of Ki=0.73±0.2nM and for ERα of Ki=6.41±1nM.
- GC49563FenhexamidCAS: 126833-17-8Purity: >98.00%
Fenhexamid, a botryticide, is a sterol biosynthesis inhibitor.
- GC496092-bromo 17β-EstradiolCAS: 15833-07-5Purity: >98.00%
A synthetic steroid and inhibitor of estrogen 2-hydroxylase
- GC49757Bazedoxifene N-oxideCAS: 1174289-22-5Purity: >90.00%
An oxidative degradation product of bazedoxifene
- GC49878Fulvestrant 9-sulfoneCAS: 98008-06-1Purity: >98.00%
An estrogen receptor antagonist and a derivative of fulvestrant
- GC52180WAY-169916CAS: 669764-18-5Purity: >98.00%
WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity.
- GC52189NomegestrolCAS: 58691-88-6Purity: >95.00%
Nomegestrol is a potent and orally available progestin, acts as a selective full progesterone receptor agonist, with a Kd of 5.44 nM for rat uterine progesterone receptor, and has moderate antiandrogenic activity and strong antiestrogenic activity.
- GC523654-tert-Octylphenol monoethoxylateCAS: 2315-67-5Purity: >98.00%
An alkylphenolethoxylate and a degradation product of non-ionic surfactants
- GC61267SAR439859CAS: 2114339-57-8Purity: >99.50%
SAR439859 (compound 43d) is an orally active, nonsteroidal and selective estrogen receptor degrader (SERD). SAR439859 is a potent ER antagonist and has ER degrading activity with an EC50 of 0.2 nM for ERα degradation. SAR439859 demonstrates robust antitumor efficacy and limited cross-resistance in ER+ breast cancer.
- GC62061Melengestrol acetateCAS: 2919-66-6Purity: >99.50%
Melengestrol acetate is a progesterone derivative, acts as an orally active corticosteroid hormone to promote endometrial proliferation, pregnancy maintenance, and delay of menstrual activity.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC48979 | Estradiol 17-(β-D-Glucuronide) (sodium salt hydrate) | - | >95.00% | |
A substrate of multidrug resistance protein 2 | ||||
| GC49025 | Desogestrel-13C2-d2 | - | >99.00% | |
An internal standard for the quantification of desogestrel | ||||
| GC49068 | 16-Epiestriol | 547-81-9 | >90.00% | |
A metabolite of estrone | ||||
| GC49161 | 16α-hydroxy Dehydroepiandrosterone | 1232-73-1 | >95.00% | |
A metabolite of dehydroepiandrosterone | ||||
| GC49172 | 2-hydroxy Estrone | 362-06-1 | >95.00% | |
An active metabolite of estrone | ||||
| GC49189 | (E/Z)-4-hydroxy Tamoxifen-d5 | 2470232-57-4 | >99.00% | |
An internal standard for the quantification of (E/Z)-4-hydroxy tamoxifen | ||||
| GC49254 | Estrone-3-Glucuronide (sodium salt hydrate) | - | >98.00% | |
A metabolite of 17β-estradiol | ||||
| GC49326 | 5β-Dihydroprogesterone | 128-23-4 | >95.00% | |
A progesterone receptor agonist and metabolite of progesterone | ||||
| GC49391 | 7α-Thiospironolactone | 38753-76-3 | >90.00% | |
An active metabolite of spironolactone | ||||
| GC49520 | (S)-Equol | 531-95-3 | >99.00% | |
(S)-Equol is an isoflavone compound produced by the gut microbiota of some individuals, primarily derived from the metabolism of daidzein in soybeans by specific gut bacteria. (S)-Equol exhibits significant estrogenic activity and antioxidant properties, binding to estrogen receptors with an affinity for ERβ of Ki=0.73±0.2nM and for ERα of Ki=6.41±1nM. | ||||
| GC49562 | 4-methoxy Estrone | 58562-33-7 | >95.00% | |
An active metabolite of estrone | ||||
| GC49563 | Fenhexamid | 126833-17-8 | >98.00% | |
Fenhexamid, a botryticide, is a sterol biosynthesis inhibitor. | ||||
| GC49609 | 2-bromo 17β-Estradiol | 15833-07-5 | >98.00% | |
A synthetic steroid and inhibitor of estrogen 2-hydroxylase | ||||
| GC49757 | Bazedoxifene N-oxide | 1174289-22-5 | >90.00% | |
An oxidative degradation product of bazedoxifene | ||||
| GC49848 | 16-Ketoestradiol | 566-75-6 | >95.00% | |
An active metabolite of estrone | ||||
| GC49878 | Fulvestrant 9-sulfone | 98008-06-1 | >98.00% | |
An estrogen receptor antagonist and a derivative of fulvestrant | ||||
| GC50091 | AC 186 | 1421854-16-1 | >98% | |
Potent and selective ERβ agonist; neuroprotective | ||||
| GC52180 | WAY-169916 | 669764-18-5 | >98.00% | |
WAY-169916 is a pathway-selective ligand of ER (estrogen receptor) that acts by inhibiting NF-kB transcriptional activity. | ||||
| GC52189 | Nomegestrol | 58691-88-6 | >95.00% | |
Nomegestrol is a potent and orally available progestin, acts as a selective full progesterone receptor agonist, with a Kd of 5.44 nM for rat uterine progesterone receptor, and has moderate antiandrogenic activity and strong antiestrogenic activity. | ||||
| GC52365 | 4-tert-Octylphenol monoethoxylate | 2315-67-5 | >98.00% | |
An alkylphenolethoxylate and a degradation product of non-ionic surfactants | ||||
| GC52420 | Drospirenone-13C3 | - | >95.00% | |
An internal standard for the quantification of drospirenone | ||||
| GC61267 | SAR439859 | 2114339-57-8 | >99.50% | |
SAR439859 (compound 43d) is an orally active, nonsteroidal and selective estrogen receptor degrader (SERD). SAR439859 is a potent ER antagonist and has ER degrading activity with an EC50 of 0.2 nM for ERα degradation. SAR439859 demonstrates robust antitumor efficacy and limited cross-resistance in ER+ breast cancer. | ||||
| GC61971 | Liarozole | 115575-11-6 | >98.50% | |
Liarozole (R75251; R85246) is an imidazole derivative and orally active retinoic acid (RA) metabolism-blocking agent (RAMBA). | ||||
| GC62061 | Melengestrol acetate | 2919-66-6 | >99.50% | |
Melengestrol acetate is a progesterone derivative, acts as an orally active corticosteroid hormone to promote endometrial proliferation, pregnancy maintenance, and delay of menstrual activity. | ||||
